Moderna Inc(MRNA-Q)NASDAQ
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Moderna Inc
325 BINNEY STREETCAMBRIDGE MA 02142 USA
P: 617-714-6500
F: 617-583-1998
http://www.modernatx.com
Profile
Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 vaccine. The company has also developed booster doses of its COVID-19 vaccine and is developing variant-specific booster candidates.
Key Executives
| Name | Title |
|---|---|
| Information not available. | |